Drug Trial Radar · NCT03937505
A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy
Last checked: Nov 19, 2026Latest source record: Aug 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
94
Actual
Start
May 28, 2019
Primary completion
Jul 8, 2021
Study completion Jul 22, 2021
Sponsor
- Lead sponsor
- Intuitive SurgicalIndustry
- Sponsor type
- Industry
- First posted
- May 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation. Stage A of the study will determine the safe optimal dose and Stage B will determine expanded safety and efficacy for intraoperative ureter structure delineation for the identified optimal dose in study participants.
Conditions
- Ureter Injury
Interventions
IS-001Drug
intravenous injection of IS-001 investigational drug
No treatmentDrug
no drug injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate fluorescent intensity of ureter by signal to background analysisTime frame: 10 minutes
- Evaluate fluorescent intensity of ureter by signal to background analysisTime frame: 30 minutes
- Evaluate fluorescent intensity of ureter by signal to background analysisTime frame: 60 minutes
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
George Washington University Hospital
Washington D.C., District of Columbia
St.David's Medical Center
Austin, Texas
Las Palmas Medical Center
El Paso, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.